| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |